Biagi JJ, Seymour JF (2002) Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation. Blood 99:4265–4275. https://doi.org/10.1182/blood.v99.12.4265

Article  PubMed  CAS  Google Scholar 

Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 107:265–276. https://doi.org/10.1182/blood-2005-06-2508

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, Marcos-Gragera R, Maynadie M, Simonetti A, Lutz JM, Berrino F, Group HW (2010) Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 116:3724–3734. https://doi.org/10.1182/blood-2010-05-282632

Article  PubMed  CAS  Google Scholar 

Shirley MH, Sayeed S, Barnes I, Finlayson A, Ali R (2013) Incidence of haematological malignancies by ethnic group in England, 2001–7. Br J Haematol 163:465–477. https://doi.org/10.1111/bjh.12562

Article  PubMed  Google Scholar 

J.C. FASA (2022) Clinical manifestations, pathologic features, diagnosis, and prognosis of follicular lymphoma UpToDate

Aster JC, Kobayashi Y, Shiota M, Mori S, Sklar J (1992) Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients. Am J Pathol 141:291–299

PubMed  PubMed Central  CAS  Google Scholar 

Limpens J, de Jong D, van Krieken JH, Price CG, Young BD, van Ommen GJ, Kluin PM (1991) Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6:2271–2276

PubMed  CAS  Google Scholar 

Ghia P, Boussiotis VA, Schultze JL, Cardoso AA, Dorfman DM, Gribben JG, Freedman AS, Nadler LM (1998) Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival. Blood 91:244–251

Article  PubMed  CAS  Google Scholar 

Yang E, Korsmeyer SJ (1996) Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88:386–401

Article  PubMed  CAS  Google Scholar 

Cheung KJ, Shah SP, Steidl C, Johnson N, Relander T, Telenius A, Lai B, Murphy KP, Lam W, Al-Tourah AJ, Connors JM, Ng RT, Gascoyne RD, Horsman DE (2009) Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances. Blood 113:137–148. https://doi.org/10.1182/blood-2008-02-140616

Article  PubMed  CAS  Google Scholar 

Schwaenen C, Viardot A, Berger H, Barth TF, Bentink S, Dohner H, Enz M, Feller AC, Hansmann ML, Hummel M, Kestler HA, Klapper W, Kreuz M, Lenze D, Loeffler M, Moller P, Muller-Hermelink HK, Ott G, Rosolowski M, Rosenwald A, Ruf S, Siebert R, Spang R, Stein H, Truemper L, Lichter P, Bentz M, Wessendorf S (2009) Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche K Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status. Genes Chrom Cancer 48:39–54. https://doi.org/10.1002/gcc.20617

Article  PubMed  CAS  Google Scholar 

Launay E, Pangault C, Bertrand P, Jardin F, Lamy T, Tilly H, Tarte K, Bastard C, Fest T (2012) High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis. Leukemia 26:559–562. https://doi.org/10.1038/leu.2011.266

Article  PubMed  CAS  Google Scholar 

Bosga-Bouwer AG, van Imhoff GW, Boonstra R, van der Veen A, Haralambieva E, van den Berg A, de Jong B, Krause V, Palmer MC, Coupland R, Kluin PM, van den Berg E, Poppema S (2003) Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood 101:1149–1154. https://doi.org/10.1182/blood.V101.3.1149

Article  PubMed  CAS  Google Scholar 

Diaz-Alderete A, Doval A, Camacho F, Verde L, Sabin P, Arranz-Saez R, Bellas C, Corbacho C, Gil J, Perez-Martin M, Ruiz-Marcellan M, Gonzalez L, Montalban C, Piris M, Menarguez J (2008) Frequency of BCL2 and BCL6 translocations in follicular lymphoma: relation with histological and clinical features. Leuk Lymphoma 49:95–101. https://doi.org/10.1080/10428190701742472

Article  PubMed  CAS  Google Scholar 

Bodor C, Grossmann V, Popov N, Okosun J, O’Riain C, Tan K, Marzec J, Araf S, Wang J, Lee AM, Clear A, Montoto S, Matthews J, Iqbal S, Rajnai H, Rosenwald A, Ott G, Campo E, Rimsza LM, Smeland EB, Chan WC, Braziel RM, Staudt LM, Wright G, Lister TA, Elemento O, Hills R, Gribben JG, Chelala C, Matolcsy A, Kohlmann A, Haferlach T, Gascoyne RD, Fitzgibbon J (2013) EZH2 mutations are frequent and represent an early event in follicular lymphoma. Blood 122:3165–3168. https://doi.org/10.1182/blood-2013-04-496893

Article  PubMed  PubMed Central  CAS  Google Scholar 

Green MR (2018) Chromatin modifying gene mutations in follicular lymphoma. Blood 131:595–604. https://doi.org/10.1182/blood-2017-08-737361

Article  PubMed  PubMed Central  CAS  Google Scholar 

Green MR, Gentles AJ, Nair RV, Irish JM, Kihira S, Liu CL, Kela I, Hopmans ES, Myklebust JH, Ji H, Plevritis SK, Levy R, Alizadeh AA (2013) Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood 121:1604–1611. https://doi.org/10.1182/blood-2012-09-457283

Article  PubMed  PubMed Central  CAS  Google Scholar 

Green MR, Kihira S, Liu CL, Nair RV, Salari R, Gentles AJ, Irish J, Stehr H, Vicente-Duenas C, Romero-Camarero I, Sanchez-Garcia I, Plevritis SK, Arber DA, Batzoglou S, Levy R, Alizadeh AA (2015) Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation. Proc Natl Acad Sci U S A 112:E1116-1125. https://doi.org/10.1073/pnas.1501199112

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kridel R, Chan FC, Mottok A, Boyle M, Farinha P, Tan K, Meissner B, Bashashati A, McPherson A, Roth A, Shumansky K, Yap D, Ben-Neriah S, Rosner J, Smith MA, Nielsen C, Gine E, Telenius A, Ennishi D, Mungall A, Moore R, Morin RD, Johnson NA, Sehn LH, Tousseyn T, Dogan A, Connors JM, Scott DW, Steidl C, Marra MA, Gascoyne RD, Shah SP (2016) Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study. PLoS Med 13:e1002197. https://doi.org/10.1371/journal.pmed.1002197

Article  PubMed  PubMed Central  CAS  Google Scholar 

Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, Jackman S, Krzywinski M, Scott DW, Trinh DL, Tamura-Wells J, Li S, Firme MR, Rogic S, Griffith M, Chan S, Yakovenko O, Meyer IM, Zhao EY, Smailus D, Moksa M, Chittaranjan S, Rimsza L, Brooks-Wilson A, Spinelli JJ, Ben-Neriah S, Meissner B, Woolcock B, Boyle M, McDonald H, Tam A, Zhao Y, Delaney A, Zeng T, Tse K, Butterfield Y, Birol I, Holt R, Schein J, Horsman DE, Moore R, Jones SJ, Connors JM, Hirst M, Gascoyne RD, Marra MA (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476:298–303. https://doi.org/10.1038/nature10351

Article  ADS  PubMed  PubMed Central  CAS  Google Scholar 

Okosun J, Bodor C, Wang J, Araf S, Yang CY, Pan C, Boller S, Cittaro D, Bozek M, Iqbal S, Matthews J, Wrench D, Marzec J, Tawana K, Popov N, O’Riain C, O’Shea D, Carlotti E, Davies A, Lawrie CH, Matolcsy A, Calaminici M, Norton A, Byers RJ, Mein C, Stupka E, Lister TA, Lenz G, Montoto S, Gribben JG, Fan Y, Grosschedl R, Chelala C, Fitzgibbon J (2014) Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nat Genet 46:176–181. https://doi.org/10.1038/ng.2856

Article  PubMed  CAS  Google Scholar 

Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, Kasper LH, Lerach S, Tang H, Ma J, Rossi D, Chadburn A, Murty VV, Mullighan CG, Gaidano G, Rabadan R, Brindle PK, Dalla-Favera R (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471:189–195. https://doi.org/10.1038/nature09730

Article  ADS  PubMed  PubMed Central  CAS  Google Scholar 

Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB, Ouillette P, Trifonov V, Rossi D, Tabbo F, Ponzoni M, Chadburn A, Murty VV, Bhagat G, Gaidano G, Inghirami G, Malek SN, Rabadan R, Dalla-Favera R (2014) Genetics of follicular lymphoma transformation Cell. Rep 6:130–140. https://doi.org/10.1016/j.celrep.2013.12.027

Article  CAS  Google Scholar 

Nann D, Ramis-Zaldivar JE, Muller I, Gonzalez-Farre B, Schmidt J, Egan C, Salmeron-Villalobos J, Clot G, Mattern S, Otto F, Mankel B, Colomer D, Balague O, Szablewski V, Lome-Maldonado C, Leoncini L, Dojcinov S, Chott A, Copie-Bergman C, Bonzheim I, Fend F, Jaffe ES, Campo E, Salaverria I, Quintanilla-Martinez L (2020) Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease. Blood Adv 4:5652–5665. https://doi.org/10.1182/bloodadvances.2020002944

Article  PubMed  PubMed Central  CAS  Google Scholar 

Los-de Vries GT, Stevens WBC, van Dijk E, Langois-Jacques C, Clear AJ, Stathi P, Roemer MGM, Mendeville M, Hijmering NJ, Sander B, Rosenwald A, Calaminici M, Hoster E, Hiddemann W, Gaulard P, Salles G, Horn H, Klapper W, Xerri L, Burton C, Tooze RM, Smith AG, Buske C, Scott DW, Natkunam Y, Advani R, Sehn LH, Raemaekers J, Gribben J, Kimby E, Kersten MJ, Maucort-Boulch D, Ylstra B, de Jong D (2022) Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV. Blood Adv 6:5482–5493. https://doi.org/10.1182/bloodadvances.2022008355

Article  PubMed  PubMed Central  CAS  Google Scholar 

J.C. FASA (2022) Epidemiology, clinical manifestations, pathologic features, and diagnosis of diffuse large B cell lymphoma UpToDate

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Swerdlow SH et al. IARC, Lyon, 2017.

J.C. BJRFASA (2022) Pathobiology of diffuse large B cell lymphoma and primary mediastinal large B cell lymphoma UpToDate

Carreras J, Hamoudi R, Nakamura N (2020) Artificial Intelligence Analysis of Gene Expression Data Predicted the Prognosis of Patients with Diffuse Large B-Cell Lymphoma. Tokai J Exp Clin Med 45:37–48

PubMed  Google Scholar 

Carreras J, Hiraiwa S, Kikuti YY, Miyaoka M, Tomita S, Ikoma H, Ito A, Kondo Y, Roncador G, Garcia JF, Ando K, Hamoudi R, Nakamura N (2021) Artificial Neural Networks Predicted the Overall Survival and Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Pancancer Immune-Oncology Panel Cancers (Basel) 13. https://doi.org/10.3390/cancers13246384

Carreras J, Kikuti YY, Hiraiwa S, Miyaoka M, Tomita S, Ikoma H, Ito A, Kondo Y, Itoh J, Roncador G, Martinez A, Colomo L, Hamoudi R, Ando K, Nakamura N (2022) High PTX3 expression is associated with a poor prognosis in diffuse large. B-cell lymphoma Cancer Sci 113:334–348. https://doi.org/10.1111/cas.15179

Article  PubMed  CAS  Google Scholar